[Muromonab CD3]

Nihon Rinsho. 2005 May:63 Suppl 5:747-50.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Acute Disease
  • Animals
  • Antibodies, Monoclonal* / administration & dosage
  • Antibodies, Monoclonal* / adverse effects
  • CD3 Complex / immunology
  • Cytomegalovirus Infections / etiology
  • Graft Rejection / drug therapy*
  • Humans
  • Immunosuppressive Agents* / administration & dosage
  • Immunosuppressive Agents* / adverse effects
  • Infusions, Intravenous
  • Kidney Transplantation
  • Muromonab-CD3* / administration & dosage
  • Muromonab-CD3* / adverse effects
  • Pulmonary Edema / etiology
  • Receptors, Antigen, T-Cell / immunology
  • T-Lymphocytes / immunology

Substances

  • Antibodies, Monoclonal
  • CD3 Complex
  • Immunosuppressive Agents
  • Muromonab-CD3
  • Receptors, Antigen, T-Cell